Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SOLARA ACTIVE PHARMA SCIENCES ZYDUS LIFESCIENCES SOLARA ACTIVE PHARMA SCIENCES/
ZYDUS LIFESCIENCES
 
P/E (TTM) x -6.8 22.1 - View Chart
P/BV x 3.9 4.8 81.9% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 SOLARA ACTIVE PHARMA SCIENCES   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    SOLARA ACTIVE PHARMA SCIENCES
Mar-24
ZYDUS LIFESCIENCES
Mar-24
SOLARA ACTIVE PHARMA SCIENCES/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs5071,030 49.2%   
Low Rs287483 59.5%   
Sales per share (Unadj.) Rs358.0194.3 184.3%  
Earnings per share (Unadj.) Rs-157.538.1 -413.6%  
Cash flow per share (Unadj.) Rs-128.845.7 -282.0%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs259.0197.1 131.4%  
Shares outstanding (eoy) m36.001,006.23 3.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.13.9 28.5%   
Avg P/E ratio x-2.519.9 -12.7%  
P/CF ratio (eoy) x-3.116.6 -18.6%  
Price / Book Value ratio x1.53.8 39.9%  
Dividend payout %07.9 -0.0%   
Avg Mkt Cap Rs m14,294761,065 1.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,43927,890 8.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,889195,474 6.6%  
Other income Rs m543,694 1.5%   
Total revenues Rs m12,943199,168 6.5%   
Gross profit Rs m-2,85452,848 -5.4%  
Depreciation Rs m1,0337,641 13.5%   
Interest Rs m1,051812 129.4%   
Profit before tax Rs m-4,88448,089 -10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7859,775 8.0%   
Profit after tax Rs m-5,67038,314 -14.8%  
Gross profit margin %-22.127.0 -81.9%  
Effective tax rate %-16.120.3 -79.1%   
Net profit margin %-44.019.6 -224.4%  
BALANCE SHEET DATA
Current assets Rs m7,881114,198 6.9%   
Current liabilities Rs m12,42853,397 23.3%   
Net working cap to sales %-35.331.1 -113.4%  
Current ratio x0.62.1 29.7%  
Inventory Days Days730 24.7%  
Debtors Days Days1097 10.1%  
Net fixed assets Rs m15,502161,352 9.6%   
Share capital Rs m3601,006 35.8%   
"Free" reserves Rs m8,963197,289 4.5%   
Net worth Rs m9,323198,295 4.7%   
Long term debt Rs m1,0580-   
Total assets Rs m23,510276,366 8.5%  
Interest coverage x-3.660.2 -6.1%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.50.7 77.5%   
Return on assets %-19.614.2 -138.8%  
Return on equity %-60.819.3 -314.8%  
Return on capital %-36.924.7 -149.7%  
Exports to sales %043.0 0.0%   
Imports to sales %09.9 0.0%   
Exports (fob) Rs mNA84,117 0.0%   
Imports (cif) Rs mNA19,274 0.0%   
Fx inflow Rs m084,117 0.0%   
Fx outflow Rs m019,274 0.0%   
Net fx Rs m064,843 0.0%   
CASH FLOW
From Operations Rs m1,08932,279 3.4%  
From Investments Rs m-35-14,752 0.2%  
From Financial Activity Rs m-1,057-18,104 5.8%  
Net Cashflow Rs m-3-748 0.4%  

Share Holding

Indian Promoters % 37.3 75.0 49.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 17.6 18.2 97.0%  
FIIs % 14.3 7.5 189.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 62.7 25.0 250.7%  
Shareholders   71,882 370,863 19.4%  
Pledged promoter(s) holding % 38.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SOLARA ACTIVE PHARMA SCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on SOLARA ACTIVE PHARMA SCIENCES vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SOLARA ACTIVE PHARMA SCIENCES vs Cadila Healthcare Share Price Performance

Period SOLARA ACTIVE PHARMA SCIENCES Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.09% -0.28% 0.11%
1-Month -7.60% -6.06% -3.22%
1-Year 127.10% 47.78% 42.65%
3-Year CAGR -9.03% 27.44% 19.86%
5-Year CAGR 10.58% 30.01% 25.90%

* Compound Annual Growth Rate

Here are more details on the SOLARA ACTIVE PHARMA SCIENCES share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of SOLARA ACTIVE PHARMA SCIENCES hold a 37.3% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SOLARA ACTIVE PHARMA SCIENCES and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, SOLARA ACTIVE PHARMA SCIENCES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Cadila Healthcare paid Rs 3.0, and its dividend payout ratio stood at 7.9%.

You may visit here to review the dividend history of SOLARA ACTIVE PHARMA SCIENCES, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.